Prevalence of HbA1C in Women With PCOS (WHI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01838122|
Recruitment Status : Unknown
Verified April 2013 by M.R. Bharucha, Southern Cross Fertility Centre.
Recruitment status was: Active, not recruiting
First Posted : April 23, 2013
Last Update Posted : April 23, 2013
|Condition or disease|
|Polycystic Ovarian Syndrome Pelvic Endometriosis Insulin Resistance Non-insulin Dependent Diabetes Mellitus Tubal Obstruction|
In view of recent suggestion of American Diabetes Association(ADA)to screen women with PCOS for HbA1C,we intend to study its prevalence in all categories of obesity in women with PCOS.
Women with PCOS by Rotterdam criteria will be screened for insulin resistance by using different techniques or tests.
Further, the sensitivity and specificity of HbA1C will be compared with sensitivity and specificity of other insulin resistance markers such as OGTT, Free androgen index, free testosterone, fasting insulin to glucose ratio, HOMA-IR and HOMA-B-CELL.
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Prevalence of HbA1C in Different Categories of Obesity in Women With PCOS'A Propective Randomized Control Study|
|Study Start Date :||April 2013|
|Estimated Primary Completion Date :||September 2013|
|Estimated Study Completion Date :||November 2013|
This group/cohort will have subjects having infertility due to PCOS (as per Rotterdam criteria)
This group/cohort will have subjects without PCOS but with any other diagnosis of infertility or any other complain.
- Prevalence of HbA1C in both arms of the cohort of subjects [ Time Frame: September 2013 ]HbA1C has been suggested as a potential marker for NIDDM in subjects with PCOS
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01838122
|Southern Cross Fertility Centre|
|Mumbai, Maharashtra, India, 400025|
|Study Director:||Manchi R Bharucha, Ph.D||Southern Cross Fertility Centre|
|Study Director:||Manchi R Bharucha, Ph.D.||Souther Cross Fertility Centre|